Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study-Reference-Cited by-同舟云学术

Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study

Published:2022-02-15 Issue:8 Volume:38 Page:1267-1274
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Dillon Larry D.¹,McPhee Michael²,Davidson Robert S.³,Quick Ann P.⁴^ORCID,Martin Brian⁴,Covington Kyle R.⁴,Zolochevska Olga⁴,Cook Robert W.⁴,Vetto John T.⁵,Jarell Abel D.⁶,Fleming Martin D.⁷

Affiliation:

1. Larry D. Dillon Surgical Oncology and General Surgery, Colorado Springs, CO, USA

2. Breast Cancer Program, Advent Health Cancer Institute, Orlando, FL, USA

3. Department of Surgical Oncology, Morton Plant Mease Healthcare, FL, USA

4. Castle Biosciences, Inc, Friendswood, TX, USA

5. Department of Neurology, Surgical Oncology, Oregon Health & Science University, Portland, OR, USA

6. Department of Dermatology, Northeast Dermatology Associates, P.C., Portsmouth, NH, USA

7. Department of Surgical Oncology, The University of Tennessee Health Science Center, Memphis, TN, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2022.2033560

Reference35 articles.

1. American Cancer Society. Cancer Facts & Figures 2019. 2019. 76. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2019.html.

2. Surveillance imaging for metastasis in high-risk melanoma: importance in individualized patient care and survivorship

3. Imaging Intensity and Survival Outcomes in High-Risk Resected Melanoma Treated by Systemic Therapy at Recurrence

4. Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?

5. Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of melanoma: can we use gene expression profiling to help guide treatment and surveillance?;Clinical & Experimental Metastasis;2023-12-08

2. The Integrated i31-GEP Test Outperforms the MSKCC Nomogram at Predicting SLN Status in Melanoma Patients;Anticancer Research;2023-09-29

3. Sentinel lymph node assessment in melanoma: current state and future directions;Histopathology;2023-08

4. 31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration;JCO Precision Oncology;2023-06

5. The 31-gene expression profile test informs sentinel lymph node biopsy decisions in patients with cutaneous melanoma: results of a prospective, multicenter study;Current Medical Research and Opinion;2023-01-16